Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 11/20 | 0.34 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9885159 | 0.87 | GAA (0.37) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL9885158 | 0.87 | GAA (0.37) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL12668888 | 0.85 | GAA (0.35) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL4288397 | 0.85 | GAA (0.35) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL9885163 | 0.83 | NPC1 (0.41) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL12730032 | 0.82 | GPR35 (0.41) | GPR35CYP3A4MAPTALDH1A1MEN1 | |
| SCHEMBL9885161 | 0.82 | GAA (0.33) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL15961718 | 0.82 | GAA (0.33) | GAANPC1MAPK1RAB9ATLR8 | |
| SCHEMBL1108985 | 0.81 | GPR35 (0.32) | TLR8GPR35CYP3A4MAPTMEN1 | |
| SCHEMBL17188250 | 0.80 | GPR35 (0.32) | GPR35CYP3A4MAPTMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2085401-B1 | Benzobisthiazole compound, benzobisthiazole polymer, organic film including the compound or polymer and transistor including the organic film | RICOH CO LTD (JP) | 2014-07-30 | — | — | EP | disclosed |
| US-8193304-B2 | Benzobisthiazole compound, benzobisthiazole polymer, organic film including the compound or polymer and transistor including the organic film | RICOH COMPANY LIMITED (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20090230386-A1 | BENZOBISTHIAZOLE COMPOUND, BENZOBISTHIAZOLE POLYMER, ORGANIC FILM INCLUDING THE COMPOUND OR POLYMER AND TRANSISTOR INCLUDING THE ORGANIC FILM | RICOH COMPANY LIMITED (JP) | 2009-09-17 | — | — | US | disclosed |
| EP-2085401-A1 | Benzobisthiazole compound, benzobisthiazole polymer, organic film including the compound or polymer and transistor including the organic film | Ricoh Company, Ltd. (JP) | 2009-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090230386-A1 | BENZOBISTHIAZOLE COMPOUND, BENZOBISTHIAZOLE POLYMER, ORGANIC FILM INCLUDING THE COMPOUND OR POLYMER AND TRANSISTOR INCLUDING THE ORGANIC FILM | CYP3A43, CYP2C19, SLCO1B3 | GAA 2862/4885NPC1 3976/4885MAPK1 1110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.